Global BRAF Kinase Inhibitor Market

The global BRAF kinase inhibitor market accounted for US$ 879.3 million in 2020 and is estimated to be US$ 2007.5 million by 2030 and is anticipated to register a CAGR of 8.7%. BRAF is a kinase enzyme that helps in controlling cell growth and signaling which can be founded in mutated condition for some types of cancer, including melanoma and colorectal cancer. Blocking mutated BRAF kinase proteins helps to stop the cancer cells from growing and some BRAF kinase inhibitor are used for treatment of cancer. BRAF codes for protein called B-RAF and also referred as proto-oncogene B-RAF and V-BRAF murine sarcoma viral oncogene homolog B whereas protein is known as serine/threonine-protein kinase B-RAF. 

The report " Global BRAF Kinase Inhibitor Market, By Drug (Vemurafenib, Dabrafenib and Encorafenib), By Indication (Metastatic Melanoma, Metastatic Lung Cancer and Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”

Key Highlights:

• In July 2020, Roche got the approval from U.S. Food and Drug Administration of Tecentriq (atezolizumab) plus Cotellic (cobimetinib) and Zelboraf (vemurafenib) for the treatment of BRAF V600 mutation-positive.
• In June 2020, BeiGene, Ltd., a commercial-stage biotechnology company and SpringWorks Therapeutics, Inc., a clinical-stage biopharmaceutical company, announced about their presentation of preclinical data and provided a program update on their ongoing Phase 1b/2 study evaluating the combination of BeiGene’s investigational RAF dimer inhibitor, lifirafenib, with SpringWorks’ investigational MEK inhibitor, mirdametinib, in patients with advanced or refractory solid tumors harboring mutations in the MAPK pathway, including those with RAS mutations.

Analyst View:

Increasing incidence of cancers is the major growth driver of global BRAF kinase inhibitor market. Many key players are coming with new drugs and new technologies like topical sildenafil, nicotine patches, and topical allopurinol to overcome this syndrome. Various organizations such as W.H.O., FEAT, and others along with the government are spreading awareness about this syndrome condition which is anticipated to facilitate market growth in the forecast period.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global BRAF Kinase Inhibitor Market, By Drug (Vemurafenib, Dabrafenib and Encorafenib), By Indication (Metastatic Melanoma, Metastatic Lung Cancer and Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”

Request for a Fresh Look@

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4669

Key Market Insights from the report:

The global BRAF kinase inhibitor market market accounted for US$ 879.3 million in 2020 and is estimated to be US$ 2007.5 million by 2030 and is anticipated to register a CAGR of 8.7%. The Global BRAF Kinase Inhibitor market is segmented based on the drug, indication, distribution channel and region.

• By Drug, the Global BRAF Kinase Inhibitor market is segmented into Vemurafenib, Dabrafenib and Encorafenib.
• By Indication, the market is segmented in Metastatic Melanoma, Metastatic Lung Cancer and Others.
• By Distribution Channel, the Global BRAF Kinase Inhibitor market is segmented into Hospital pharmacies, Online pharmacies and Others.
• By region, the Global BRAF Kinase Inhibitor market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the worldwide leader in the BRAF kinase inhibitor market in terms of revenue, due to the developed healthcare system and health awareness among people.

Competitive Landscape:

The key players operating in the Global BRAF Kinase Inhibitor market include F. Hoffmann-La Roche Ltd., and Novartis AG.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

• Explains an overview of the product portfolio, including product development, planning, and positioning
• Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
• Detailed analysis of the market revenue over the forecasted period.
• Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
• Study on the segments that are anticipated to dominate the market.
• Study on the regional analysis that is expected to register the highest growth over the forecast period

Key Topics Covered

1. Introduction

• Study Deliverables
• Study Assumptions
• Scope of the Study

1. Research Methodology
2. Executive Summary

• Opportunity Map Analysis
• Market at Glance
• Market Share (%) and BPS Analysis, by Region
• Competitive Landscape
• Heat Map Analysis 
• Market Presence and Specificity Analysis

1. Investment Analysis
2. Competitive Analysis

To know more

Contact Us:

Sales

Prophecy Market Insights

  1 860 531 2701

Email- sales@prophecymarketinsights.com